Racura Oncology Ltd
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.03 AUD
−4.79 M AUD
0.00 AUD
123.72 M
About Racura Oncology Ltd
Sector
Industry
CEO
Daniel Tillett
Website
Headquarters
Sydney
Founded
2011
IPO date
Jul 13, 2016
IPO offer price
0.15 USD
Identifiers
2
ISINAU000000RAC3
Racura Oncology Ltd. is a Phase 3 clinical biopharmaceutical company with a dedicated mission to be at the heart of cancer care. The firm is involved in RCDS1, is a small molecule anticancer agent that primarily functions via G4-DNA & RNA binding, to potent inhibition of the important cancer growth regulator MYC. The company was founded on February 15, 2011 and is headquartered in Sydney, Australia.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RAC is 2.82 AUD — it has increased by 1.08% in the past 24 hours. Watch Racura Oncology Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Racura Oncology Ltd stocks are traded under the ticker RAC.
RAC stock has risen by 11.02% compared to the previous week, the month change is a −4.41% fall, over the last year Racura Oncology Ltd has showed a 100.71% increase.
We've gathered analysts' opinions on Racura Oncology Ltd future price: according to them, RAC price has a max estimate of 7.46 AUD and a min estimate of 7.46 AUD. Watch RAC chart and read a more detailed Racura Oncology Ltd stock forecast: see what analysts think of Racura Oncology Ltd and suggest that you do with its stocks.
RAC stock is 6.55% volatile and has beta coefficient of −0.09. Track Racura Oncology Ltd stock price on the chart and check out the list of the most volatile stocks — is Racura Oncology Ltd there?
Today Racura Oncology Ltd has the market capitalization of 504.49 M, it has decreased by −4.35% over the last week.
Yes, you can track Racura Oncology Ltd financials in yearly and quarterly reports right on TradingView.
Racura Oncology Ltd is going to release the next earnings report on Mar 3, 2026. Keep track of upcoming events with our Earnings Calendar.
RAC net income for the last half-year is −5.29 M AUD, while the previous report showed 502.16 K AUD of net income which accounts for −1.15 K% change. Track more Racura Oncology Ltd financial stats to get the full picture.
No, RAC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RAC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Racura Oncology Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Racura Oncology Ltd technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Racura Oncology Ltd stock shows the buy signal. See more of Racura Oncology Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.